Skip to main content
Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
31.23
+1.80 (6.12%)
Mar 9, 2026, 2:40 PM EDT - Market open

Celldex Therapeutics Revenue

In the year 2025, Celldex Therapeutics had annual revenue of $1.55M, down -77.99%. Celldex Therapeutics had revenue of $121.00K in the quarter ending December 31, 2025, a decrease of -89.70%.

Revenue (ttm)
$1.55M
Revenue Growth
-77.99%
P/S Ratio
1,338.65
Revenue / Employee
$7,803
Employees
198
Market Cap
2.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.55M-5.48M-77.99%
Dec 31, 20247.02M137.00K1.99%
Dec 31, 20236.88M4.53M192.02%
Dec 31, 20222.36M-2.29M-49.32%
Dec 31, 20214.65M-2.77M-37.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ultragenyx Pharmaceutical 673.00M
Aurinia Pharmaceuticals 283.06M
Iovance Biotherapeutics 263.50M
Stoke Therapeutics 205.63M
Soleno Therapeutics 190.41M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Mesoblast 65.38M
Revenue Rankings

CLDX News

More News